Brief Report on the Detection of the EGFR T790M Mutation in Exhaled Breath Condensate from Lung Cancer Patients

被引：23

作者：

Smyth, Robert J. ^{[1
]}

Toomey, Sinead M. ^{[1
]}

Sartori, Alexander ^{[2
]}

O'Hanrahan, Emer ^{[3
]}

Cuffe, Sinead D. ^{[4
]}

Breathnach, Oscar S. ^{[5
]}

Morgan, Ross K. ^{[5
]}

Hennessy, Bryan T. ^{[1
]}

机构：

[1] Royal Coll Surgeons Ireland, Dublin, Ireland

[2] Agena Biosci GmbH, Hamburg, Germany

[3] St Vincents Univ Hosp, Dublin, Ireland

[4] St James Hosp, Dublin, Ireland

[5] Beaumont Hosp, Dublin, Ireland

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 08期

关键词：

Liquid biopsy; Biomarkers; T790M; Exhaled breath condensate; Lung cancer;

D O I：

10.1016/j.jtho.2018.04.033

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The EGFR T790M somatic mutation is the most common mechanism of resistance to tyrosine kinase inhibitors in NSCLC. Patients with advanced disease are not always amenable to repeat biopsy for further molecular analysis. Developing noninvasive methods to detect T790M in cell-free DNA in the absence of tissue is being actively investigated. Unfortunately, the low sensitivity of plasma for detection of T790M has limited its clinical use. Exhaled breath condensate (EBC) is an easily collected sample that is known to harbor cell-free DNA, including lung cancer mutations. This report details the potential utility of exhaled breath condensate in the detection of the EGFR T790M mutation. (C) 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

引用

页码：1213 / 1216

页数：4

共 15 条

[1] Immunochemical assay for deoxyribonuclease activity in body fluids
Cherepanova, Anna
Tamkovich, Svetlana
Pyshnyi, Dmitril
Kharkova, Maria
Vlassov, Valentin
Laktionov, Pavel
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 325 (1-2) : 96 - 103
[2] Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: A prospective multicenter study in a real-world setting (GFPC study 12-01)
Chouaid, Christos
Dujon, Cecile
Do, Pascal
Monnet, Isabelle
Madroszyk, Anne
Le Caer, Herve
Auliac, Jean Bernard
Berard, Henri
Thomas, Pascal
Lena, Herve
Robinet, Gilles
Baize, Nathalie
Bizieux-Thaminy, Acya
Fraboulet, Gislaine
Locher, Chrystele
Le Treut, Jacques
Hominal, Stephane
Vergnenegre, Alain
[J]. LUNG CANCER, 2014, 86 (02) : 170 - 173
[3] Assessment, origin, and implementation of breath volatile cancer markers
Haick, Hossam
Broza, Yoav Y.
Mochalski, Pawel
Ruzsanyi, Vera
Amann, Anton
[J]. CHEMICAL SOCIETY REVIEWS, 2014, 43 (05) : 1423 - 1449
[4] Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
Jenkins, Suzanne
Yang, James C-H.
Ramalingam, Suresh S.
Yu, Karen
Patel, Sabina
Weston, Susie
Hodge, Rachel
Cantarini, Mireille
Janne, Pasi A.
Mitsudomi, Tetsuya
Goss, Glenwood D.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1061 - 1070
[5] Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene
Kordiak, Jacek
Szemraj, Janusz
Hamara, Katarzyna
Bialasiewicz, Piotr
Nowak, Dariusz
[J]. RESPIRATORY MEDICINE, 2012, 106 (09) : 1293 - 1300
[6] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Lindeman, Neal I.
Cagle, Philip T.
Beasley, Mary Beth
Chitale, Dhananjay Arun
Dacic, Sanja
Giaccone, Giuseppe
Jenkins, Robert Brian
Kwiatkowski, David J.
Saldivar, Juan-Sebastian
Squire, Jeremy
Thunnissen, Erik
Ladanyi, Marc
[J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 823 - 859
[7] Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
Mok, T. S.
Wu, Y. -L.
Ahn, M. -J.
Garassino, M. C.
Kim, H. R.
Ramalingam, S. S.
Shepherd, F. A.
He, Y.
Akamatsu, H.
Theelen, W. S. M. E.
Lee, C. K.
Sebastian, M.
Templeton, A.
Mann, H.
Marotti, M.
Ghiorghiu, S.
Papadimitrakopoulou, V. A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) : 629 - 640
[8] Ultrasensitive Detection of Multiplexed Somatic Mutations Using MALDI-TOF Mass Spectrometry
Mosko, Michael J.
Nakorchevsky, Aleksey A.
Flores, Eunice
Metzler, Heath
Ehrich, Mathias
van den Boom, Dirk J.
Sherwood, James L.
Nygren, Anders O. H.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (01) : 23 - 31
[9] Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer
Nardi-Agmon, Inbar
Abud-Hawa, Manal
Liran, Ori
Gai-Mor, Naomi
Ilouze, Maya
Onn, Amir
Bar, Jair
Shlomi, Dekel
Haick, Hossam
Peled, Nir
[J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (06) : 827 - 837
[10] Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
Oxnard, Geoffrey R.
Paweletz, Cloud P.
Kuang, Yanan
Mach, Stacy L.
O'Connell, Allison
Messineo, Melissa M.
Luke, Jason J.
Butaney, Mohit
Kirschmeier, Paul
Jackman, David M.
Janne, Pasi A.
[J]. CLINICAL CANCER RESEARCH, 2014, 20 (06) : 1698 - 1705

← 1 2 →